RxDoctor Payments Data

Haley Taylor

Acute Care · Charlottesville, VANPI 1437711447

Payments from drug & device makers

$1,303in general payments, 2019–2025

Across 66 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$178
  • AstraZeneca$168
  • Novartis$166
  • Pfizer$158
  • Johnson & Johnson$87
  • Novo Nordisk$82
  • plus $465 from 13 others

What the payments were for

  • Food & beverage$1,303100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,303 in reported general payments places this provider in the 75th percentile of 599 acute care providers in Virginia.

See all acute care providers in Virginia

Medicare billing

Part B allowed, 2024
$87,160
Medicare patients
689
Services billed
1,853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban50$42,378
EntrestoSacubitril/Valsartan28$28,085
XareltoRivaroxaban12$13,726
Repatha SureclickEvolocumab14$7,710
Nebivolol Hcl13$1,698
Metoprolol Succinate104$1,235
Bumetanide35$1,227
Valsartan37$927
Amlodipine Besylate132$853
Atorvastatin Calcium56$593
Flecainide Acetate14$525
Spironolactone61$507
Amiodarone Hcl13$451
Carvedilol78$435
Losartan Potassium87$374

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$158$42,37850 claims
NovartisEntresto$166$28,08528 claims
Johnson & JohnsonXarelto$87$13,72612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 599 acute care providers in Virginia.

Other acute care in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →